These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36654039)

  • 21. Effectiveness of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 Vaccines Among US Military Personnel Before and During the Predominance of the Delta Variant.
    Eick-Cost AA; Ying S; Wells N
    JAMA Netw Open; 2022 Apr; 5(4):e228071. PubMed ID: 35442453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the transmission dynamics of measles in Japan, 2016.
    Nishiura H; Mizumoto K; Asai Y
    Epidemics; 2017 Sep; 20():67-72. PubMed ID: 28359662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of the serial interval of monkeypox during the early outbreak in 2022.
    Guo Z; Zhao S; Sun S; He D; Chong KC; Yeoh EK
    J Med Virol; 2023 Jan; 95(1):e28248. PubMed ID: 36271480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the transmissibility of SARS-CoV-2 VOC 202012/01 in Japan using travel history information.
    Kayano T; Nishiura H
    Math Biosci Eng; 2022 Jan; 19(3):2750-2761. PubMed ID: 35240804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nine-month Trend of Time-Varying Reproduction Numbers of COVID-19 in West of Iran.
    Rahimi E; Hashemi Nazari SS; Mokhayeri Y; Sharhani A; Mohammadi R
    J Res Health Sci; 2021 Jun; 21(2):e00517. PubMed ID: 34465640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproduction Number of the Omicron Variant Triples That of the Delta Variant.
    Du Z; Hong H; Wang S; Ma L; Liu C; Bai Y; Adam DC; Tian L; Wang L; Lau EHY; Cowling BJ
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of COVID-19 basic reproduction ratio in a large urban jail in the United States.
    Puglisi LB; Malloy GSP; Harvey TD; Brandeau ML; Wang EA
    Ann Epidemiol; 2021 Jan; 53():103-105. PubMed ID: 32919033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak.
    Siddle KJ; Krasilnikova LA; Moreno GK; Schaffner SF; Vostok J; Fitzgerald NA; Lemieux JE; Barkas N; Loreth C; Specht I; Tomkins-Tinch CH; Paull JS; Schaeffer B; Taylor BP; Loftness B; Johnson H; Schubert PL; Shephard HM; Doucette M; Fink T; Lang AS; Baez S; Beauchamp J; Hennigan S; Buzby E; Ash S; Brown J; Clancy S; Cofsky S; Gagne L; Hall J; Harrington R; Gionet GL; DeRuff KC; Vodzak ME; Adams GC; Dobbins ST; Slack SD; Reilly SK; Anderson LM; Cipicchio MC; DeFelice MT; Grimsby JL; Anderson SE; Blumenstiel BS; Meldrim JC; Rooke HM; Vicente G; Smith NL; Messer KS; Reagan FL; Mandese ZM; Lee MD; Ray MC; Fisher ME; Ulcena MA; Nolet CM; English SE; Larkin KL; Vernest K; Chaluvadi S; Arvidson D; Melchiono M; Covell T; Harik V; Brock-Fisher T; Dunn M; Kearns A; Hanage WP; Bernard C; Philippakis A; Lennon NJ; Gabriel SB; Gallagher GR; Smole S; Madoff LC; Brown CM; Park DJ; MacInnis BL; Sabeti PC
    Cell; 2022 Feb; 185(3):485-492.e10. PubMed ID: 35051367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.
    Thiruvengadam R; Awasthi A; Medigeshi G; Bhattacharya S; Mani S; Sivasubbu S; Shrivastava T; Samal S; Rathna Murugesan D; Koundinya Desiraju B; Kshetrapal P; Pandey R; Scaria V; Kumar Malik P; Taneja J; Binayke A; Vohra T; Zaheer A; Rathore D; Ahmad Khan N; Shaman H; Ahmed S; Kumar R; Deshpande S; Subramani C; Wadhwa N; Gupta N; Pandey AK; Bhattacharya J; Agrawal A; Vrati S; Bhatnagar S; Garg PK;
    Lancet Infect Dis; 2022 Apr; 22(4):473-482. PubMed ID: 34838183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the Transmissibility Change of 2019-Novel Coronavirus Pneumonia and Its Potential Factors in China from 2019 to 2020.
    Zhao Y; Wang R; Li J; Zhang Y; Yang H; Zhao Y
    Biomed Res Int; 2020; 2020():3842470. PubMed ID: 32461981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021.
    Kang M; Xin H; Yuan J; Ali ST; Liang Z; Zhang J; Hu T; Lau EH; Zhang Y; Zhang M; Cowling BJ; Li Y; Wu P
    Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimates of regional infectivity of COVID-19 in the United Kingdom following imposition of social distancing measures.
    Challen R; Tsaneva-Atanasova K; Pitt M; Edwards T; Gompels L; Lacasa L; Brooks-Pollock E; Danon L
    Philos Trans R Soc Lond B Biol Sci; 2021 Jul; 376(1829):20200280. PubMed ID: 34053251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.
    Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population.
    Avila-Ponce de León U; Avila-Vales E; Huang K
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
    Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Estimation of serial interval and basic reproductive number for imported cases of COVID-19].
    Estrada-Alvarez JM; Ospina-Ramírez JJ; Hincapié-Acuña M; Gómez-González MDP
    Rev Salud Publica (Bogota); 2020 Mar; 22(2):194-197. PubMed ID: 36753110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the Trajectory of Replacements of SARS-CoV-2 Variants Using Relative Reproduction Numbers.
    Piantham C; Ito K
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021.
    Ma C; Sun W; Tang T; Jia M; Liu Y; Wan Y; Han J; Rodewald L; Li J; Song Y; Wang Y; Wu D; Wang F; Zheng H; Tang L; Gao GF; Yin Z; An Z
    Vaccine; 2022 May; 40(20):2869-2874. PubMed ID: 35400561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth, reproduction numbers and factors affecting the spread of SARS-CoV-2 novel variants of concern in the UK from October 2020 to July 2021: a modelling analysis.
    Ward T; Glaser A; Johnsen A; Xu F; Hall I; Pellis L
    BMJ Open; 2021 Nov; 11(11):e056636. PubMed ID: 34819293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household.
    Yi S; Kim JM; Choe YJ; Hong S; Choi S; Ahn SB; Kim M; Park YJ
    J Korean Med Sci; 2022 Jan; 37(1):e12. PubMed ID: 34981682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.